|
| Prophylactic cranial irradiation PCI in locally advanced nonsmall cell lung cancer: time for hope |
|
https://doi.org/10.18632/oncotarget.25866
Dirk K. De Ruysscher, and Harry J. Groen
|
| 32274-32275 |
|
| Disabling an oncogenic transcription factor by targeting of control kinases |
|
https://doi.org/10.18632/oncotarget.25971
Christopher R. Vakoc, and Alex Kentsis
|
| 32276-32277 |
|
| A metabolic vulnerability of smallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.25964
Miyuki Nomura, Mami Morita, and Nobuhiro Tanuma
|
| 32278-32279 |
|
| xCT inhibition sensitizes tumors to γradiation via glutathione reduction |
|
https://doi.org/10.18632/oncotarget.25794
Lara Cobler, Hui Zhang, Poojan Suri, Catherine Park, and Luika A. Timmerman
|
| 32280-32297 |
|
| Immune checkpoint inhibitor rechallenge in patients with advanced nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25949
Maiko Niki, Aya Nakaya, Takayasu Kurata, Hiroshige Yoshioka, Toshihiko Kaneda, Kayoko Kibata, Makoto Ogata, and Shosaku Nomura
|
| 32298-32304 |
|
| Terpenes from essential oils and hydrolate of Teucrium alopecurus triggered apoptotic events dependent on caspases activation and PARP cleavage in human colon cancer cells through decreased protein expressions |
|
https://doi.org/10.18632/oncotarget.25955
Fatma Guesmi, Amit K. Tyagi, Sahdeo Prasad, and Ahmed Landoulsi
|
| 32305-32320 |
|
| Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer |
|
https://doi.org/10.18632/oncotarget.25962
Shin Nishio, Koji Matsuo, Koji Yonemoto, Mototsugu Shimokawa, Masayuki Hosaka, Michiko Kodama, Takahito M. Miyake, Kimio Ushijima, Toshiharu Kamura, Shannon N. Westin, Pamela T. Soliman, and Robert L. Coleman
|
| 32321-32330 |
|
| Snail mediates repression of the Dlk1Dio3 locus in lung tumorinfiltrating immune cells |
|
https://doi.org/10.18632/oncotarget.25965
Svenja Groeneveld, Julien Faget, Nadine Zangger, and Etienne Meylan
|
| 32331-32345 |
|
| Online structurebased screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets |
|
https://doi.org/10.18632/oncotarget.25966
Nathalie Lagarde, Julien Rey, Aram Gyulkhandanyan, Pierre Tufféry, Maria A. Miteva, and Bruno O. Villoutreix
|
| 32346-32361 |
|
| RNA based individualized drug selection in breast cancer patients without patientmatched normal tissue |
|
https://doi.org/10.18632/oncotarget.25981
Michael Forster, Adam Mark, Friederike Egberts, Elisa Rosati, Elke Rodriguez, Martin Stanulla, Dirk Bauerschlag, Christian Schem, Nicolai Maass, Anu Amallraja, Karla K. Murphy, Bruce R. Prouse, Raed A. Sulaiman, Brandon M. Young, Micaela Mathiak, Georg Hemmrich-Stanisak, David Ellinghaus, Stephan Weidinger, Philip Rosenstiel, Norbert Arnold, Brian Leyland-Jones, Casey B. Williams, Andre Franke, and Tobias Meißner
|
| 32362-32372 |
|
| Association between red and processed meat intake and colorectal adenoma incidence and recurrence: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.23561
Zhanwei Zhao, Zifang Yin, Zhenning Hang, Chaojun Zhang, and Qingchuan Zhao
|
| 32373-32382 |
|
| Spanish Lymphoma Group GELTAMO guidelines for the diagnosis staging treatment and followup of diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.25892
Eva González-Barca, Mónica Coronado, Alejandro MartÃn, Carlos Montalbán, Santiago Montes-Moreno, Carlos Panizo, Guillermo RodrÃguez, Juan Manuel Sancho, Andrés López-Hernández, and on behalf of the Spanish Lymphoma Group (GELTAMO)
|
| 32383-32399 |
|
| Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer |
|
https://doi.org/10.18632/oncotarget.26017
Joan T. Garrett, Anindita Chakrabarty, and Carlos L. Arteaga
|
| 32400-32400 |
|
| Correction: Antigenspecific T cell Redirectors: a nanoparticle based approach for redirecting T cells |
|
https://doi.org/10.18632/oncotarget.26018
Christian Schütz, Juan Carlos Varela, Karlo Perica, Carl Haupt, Mathias Oelke, and Jonathan P. Schneck
|
| 32401-32401 |
|
| Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine |
|
https://doi.org/10.18632/oncotarget.26019
Yao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, Jyun-Yan Jhan, Shui-Tein Chen, and Pei-Ming Yang
|
| 32402-32402 |
|
| Correction: Loss of EGFR signalingregulated miR203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance |
|
https://doi.org/10.18632/oncotarget.26020
Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung-Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei-Yu Chen, Lei Fang, Paul Hynes, Yao-Yu Hsieh, Yen-Nien Liu, Jiaoti Huang, and Kathleen Kelly
|
| 32403-32403 |
